Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer: Symptoms, Risc Factors, and Prevention

Odense University Hospital2 sites in 1 country100 target enrollmentAugust 2009

ConditionsProstate Cancer Androgen Deprivation Therapy Osteoporosis

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: Prostate Cancer
Sponsor: Odense University Hospital
Enrollment: 100
Locations: 2
Primary Endpoint: Osteoporosis, either T-score < -2,5 or osteoporosis fracture
Last Updated: 15 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is

to determine the rate of osteoporosis among patients with advanced prostate cancer.
to propose an algorithm for early detection of patients with advanced prostate cancer who are at risk of developing osteoporosis.

Detailed Description

Patients with advanced prostate cancer are included at the initiating of androgen deprivation therapy. The patients are followed for 2 years after inclusion with blood sampling, DXA-scan, questionnaire, bone scintigraphy.

Registry

clinicaltrials.gov

Start Date

August 2009

End Date

September 2013

Last Updated

15 years ago

Study Type

Interventional

Study Design

Single Group